Effect of icodextrin-based dialysis solution on peritoneal leptin clearance.
Opatrná
Sylvie
S
Department of Medicine I, Charles University Medical School, Pilsen, Czech Republic. opatrna@fnplzen.cz
Opatrný
Karel
K
Racek
Jaroslav
J
Sefrna
Frantisek
F
D015314:Dialysis Solutions / Q000494:pharmacology*; D005260:Female; D005936:Glucans / Q000494:pharmacology*; D005947:Glucose / Q000494:pharmacology*; D006801:Humans; D000077607:Icodextrin; D007676:Kidney Failure, Chronic / Q000628:therapy; D020738:Leptin / Q000378:metabolism*; D008297:Male; D010529:Peritoneal Cavity / Q000503:physiopathology*; D010530:Peritoneal Dialysis / Q000379:methods*; D010537:Peritoneum / Q000187:drug effects*
D015314:Dialysis Solutions; D005936:Glucans; D020738:Leptin; D000077607:Icodextrin; D005947:Glucose